Kendle International Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Kendle International Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Kendle International Inc.. The Group's principal activity is to provides Phase I-IV global clinical development services to the biopharmaceutical industry. It operates in two segments: Early Stage and Late Stage. The Early Stage segment focuses on the Group's Phase I operations, the high-end scientific exploratory medicine area. The Late Stage is comprised of clinical development services related to Phases II through IV, includes four reporting units: Global Clinical Development, Late Phase, Regulatory Affairs and Quality and Biometrics. The Global Clinical Development unit conducts Phase II and III clinical trials worldwide. The Late Phase unit designs and conducts Phase IIIB and IV studies worldwide. The Regulatory Affairs and Quality unit provides regulatory expertise and consulting services.The Biometrics unit offers customized clinical data management. It operates in the United States, Europe, Asia Pacific and Africa. In June 2008, it acquired DecisionLine Clinical Research Corporation.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report